GT Biopharma, Inc. (GTBP) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-14 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-06-12 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-05-22 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2026-04-07 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-03-02 | 8-K | Non-Reliance on Financials, Financial Statements & Exhibits | SEC |
| 2025-11-26 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2025-11-14 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-09-26 | 8-K | Item 3.03, Financial Statements & Exhibits | SEC |
| 2025-09-23 | 8-K | Item 3.03, Financial Statements & Exhibits | SEC |
| 2025-08-29 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-07-24 | 8-K | Shareholder Vote Results | SEC |
| 2025-06-11 | 8-K | Material Agreement, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-05-27 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-05-13 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2025-05-13 | 8-K | Officer / Director Changes | SEC |
| 2025-05-05 | 8-K | Officer / Director Changes | SEC |
| 2025-04-04 | 8-K | Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-02-26 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2025-01-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-27 | 8-K | Listing Notice | SEC |
| 2024-11-21 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-09-16 | 8-K | Officer / Director Changes | SEC |
| 2024-06-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-06-26 | 8-K | Shareholder Vote Results | SEC |
| 2024-06-07 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-05-23 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2024-04-30 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-02-01 | 8-K | Item 3.03, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.